57 / 100

Dr Afshana Quadiri | Vaccine | Women Researcher Award

Postdoctoral researcher, University of California, Irvine, United States 🔬

Dr. Afshana Quadiri is a dedicated researcher specializing in Vaccine Immunology, Molecular Immunology, and Virology. With a Ph.D. from the National Institute of Immunology, New Delhi, she has made significant contributions to developing vaccines for infectious diseases like malaria, SARS-CoV-2, and HSV-2. Currently serving as a Post-doctoral Fellow at the University of California, Irvine, Dr. Quadiri is focused on vaccine development and the role of chemokines in viral infections. Her innovative research and active participation in global scientific communities highlight her commitment to advancing public health. 🌍💉

Profile

Scopus

🎓 Education

Dr. Afshana Quadiri holds a Ph.D. in Immunology (2019) from the prestigious National Institute of Immunology, New Delhi, India, where she specialized in immune responses related to vaccine development. She earned her M.Sc. in Biochemistry (2013) from the University of Kashmir, India, gaining in-depth knowledge of molecular biology and biochemical processes. Her academic journey began with a B.Sc. in Biology (2010) from the Government College for Women, J&K, India, where she developed a strong foundation in biological sciences. This comprehensive educational background has equipped her with the expertise to excel in immunology and infectious disease research. 📚🧬

💼 Professional Experience

Dr. Afshana Quadiri is currently serving as a Post-doctoral Fellow (2022–Present) at the University of California Irvine, where she focuses on HSV-2 vaccine development and investigates the role of chemokines in viral infections. Previously, she worked as a Project Scientist (2019–2022) at the National Institute of Malaria Research, contributing to advancements in malaria diagnostics and conducting antiplasmodial studies. From 2018 to 2019, she was a Senior Research Fellow at the National Institute of Immunology, where she explored immune responses in the development of malaria vaccines. Additionally, in 2019, she gained experience as a Scientific Editor at Cactus Communications, where she specialized in editing scientific manuscripts. 🧪🔬

🔬 Research Interests

Dr. Quadiri’s research centers on vaccine development, immune modulation, viral immunology, and infectious diseases. She actively explores novel immunotherapies and chemokine applications to combat HSV-2, SARS-CoV-2, and malaria. Her work integrates molecular biology, immunology, and virology to design effective vaccines. 🦠💊

🏆 Awards and Fellowships

Dr. Afshana Quadiri has been recognized with several prestigious awards and fellowships throughout her academic and research career. She received the MPM Travel Grant (2018) to attend the Molecular Parasitology Meeting in Boston, highlighting her contributions to parasitology research. In 2020, she was awarded the ICMR International Travel Support to participate in the Molecular Approaches to Malaria Conference in Australia, reflecting her active engagement in global scientific discourse. Additionally, she was honored with the DBT-Fellowship for her Ph.D. studies at the National Institute of Immunology, supporting her advanced research in immunology. Dr. Quadiri also earned the Best Poster Award during Science Day at the National Institute of Immunology, recognizing her excellence in scientific presentation. 🏆🌍🔬

📚 Publications

Therapeutic Vaccination Against HSV-2 (2024) – Journal of Virology
🔗 Read here

RAGE-Ig Protein for SARS-CoV-2 Variants (2024) – Journal of Immunology
🔗 Read here

Cross-Protection SARS-CoV-2 Vaccine (2024) – Frontiers in Immunology
🔗 Read here

Spike mRNA Vaccine in Hamsters (2024) – MDPI Vaccines
🔗 Read here

CXCL11 Mucosal Vaccine for COVID-19 (2023) – Journal of Virology
🔗 Read here

Conclusion

Dr. Afshana Quadiri’s strong research background, technical expertise, and global recognition make her a highly suitable candidate for the Women Researcher Award.

Afshana Quadiri | Vaccine | Women Researcher Award

You May Also Like